STOCK TITAN

Trio Petroleum (NYSE: TPET) lifts S-3 limits, adds $65M ATM capacity

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Trio Petroleum Corp is updating its at-the-market stock offering after its public float removed prior sales limits under Form S-3. As of Amendment No. 10 to its prospectus supplement, the company may sell up to $65,000,000 of common stock as Placement Shares through its existing ATM program.

The maximum aggregate offering amount under the ATM is now $89,208,000, which includes common shares previously sold for an aggregate sales price of $24,207,305, representing 28,013,007 shares. The filing explains that as of April 14, 2026, Trio’s public float was about $77,370,054, so it is no longer subject to General Instruction I.B.6 sales limitations under Form S-3.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
New Placement Shares capacity $65,000,000 Aggregate amount of shares available for sale after Amendment No. 10
Maximum aggregate offering $89,208,000 Total ATM program size including previously sold common shares
Previously sold shares value $24,207,305 Aggregate sales price of 28,013,007 common shares already sold
Previously sold share count 28,013,007 shares Common stock sold under the prospectus supplement, as amended
Public float $77,370,054 Aggregate market value of non-affiliate common shares as of April 14, 2026
Non-affiliate shares 39,676,951 shares Outstanding common stock held by non-affiliates as of April 14, 2026
Reference share price $1.95 per share Closing price on March 3, 2026 used to calculate public float
At Market Issuance Sales Agreement financial
"entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with Ladenburg Thalmann & Co. Inc."
General Instruction I.B.6 of Form S-3 regulatory
"update the amount of shares eligible for sale under General Instruction I.B.6 of Form S-3"
prospectus supplement regulatory
"filed a prospectus supplement with the Commission covering the sale of shares of Common Stock"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
public float financial
"the Company’s outstanding shares of Common Stock held by non-affiliates, also known as the Company’s public float"
Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.
Registration Statement on Form S-3 regulatory
"under its existing Registration Statement on Form S-3 (File No 333-281813), which became effective"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.
false 0001898766 0001898766 2026-05-06 2026-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 6, 2026

 

Trio Petroleum Corp

(Exact name of registrant as specified in its charter)

 

Delaware   001-41643   87-1968201

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

23823 Malibu Road, Suite 304

Malibu, CA 90265

(661) 324-3911

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:.

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   TPET   The NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

On January 9, 2026, Trio Petroleum Corp, a Delaware corporation (the “Company”), filed a Current Report on Form 8-K (the “January 9th 8-K”) with the Securities and Exchange Commission (the “Commission”) reporting that it had entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with Ladenburg Thalmann & Co. Inc. as agent (the “Sales Agent”) pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share (“Common Stock”), from time to time through the Sales Agent (the “Offering”). On January 9, 2026, the Company also filed a prospectus supplement with the Commission covering the sale of shares of Common Stock having an aggregate offering price of up to $3,600,000, in connection with the Offering (the “Prospectus Supplement”), along with the base prospectus (the “Base Prospectus”), under its existing Registration Statement on Form S-3 (File No 333-281813), which became effective on September 10, 2024 (the “Registration Statement”).

 

On March 3, 2026, the Company filed Amendment No. 1 to the Prospectus Supplement (“Amendment No. 1”) amending and supplementing the Prospectus Supplement to update the amount of shares eligible for sale under General Instruction I.B.6 of Form S-3 (“Instruction I.B.6.). Following the filing of Amendment No. 1, the aggregate amount of shares that were available for sale was $3,292,000. The maximum aggregate offering amount was $6,892,000, which included shares of Common Stock having an aggregate sales price of $3,599,885 (7,344,372 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement.

 

On March 4, 2026, the Company filed Amendment No. 2 to the Prospectus Supplement (“Amendment No. 2”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 2, the aggregate amount of shares that were available for sale was $6,485,000. The maximum aggregate offering amount was $13,377,000, which included shares of Common Stock having an aggregate sales price of $6,891,859 (9,254,648 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On March 5, 2026, the Company filed Amendment No. 3 to the Prospectus Supplement (“Amendment No. 3”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 3, the aggregate amount of shares that were available for sale was $4,000,000. The maximum aggregate offering amount was $17,377,000, which included shares of Common Stock having an aggregate sales price of $13,376,774 (15,348,345 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On March 10, 2026, the Company filed Amendment No. 4 to the Prospectus Supplement (“Amendment No. 4”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 4, the aggregate amount of shares that were available for sale was $1,641,000. The maximum aggregate offering amount was $19,018,000, which included shares of Common Stock having an aggregate sales price of $17,375,884 (18,139,045 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On March 30, 2026, the Company filed Amendment No. 5 to the Prospectus Supplement (“Amendment No. 5”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 5, the aggregate amount of shares that were available for sale was $1,010,000. The maximum aggregate offering amount was $20,028,000, which includes shares of Common Stock having an aggregate sales price of $19,016,726 (19,202,455 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

 

 

 

On April 6, 2026, the Company filed Amendment No. 6 to the Prospectus Supplement (“Amendment No. 6”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 6, the aggregate amount of shares that were available for sale was $945,000. The maximum aggregate offering amount was $20,973,000, which includes shares of Common Stock having an aggregate sales price of $20,027,510 (20,651,554 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On April 7, 2026, the Company filed Amendment No. 7 to the Prospectus Supplement (“Amendment No. 7”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 7, the aggregate amount of shares that were available for sale was $893,000. The maximum aggregate offering amount was $21,866,000, which includes shares of Common Stock having an aggregate sales price of $20,972,479 (22,025,654 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On April 8, 2026, the Company filed Amendment No. 8 to the Prospectus Supplement (“Amendment No. 8”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 8, the aggregate amount of shares that were available for sale was $1,060,000. The maximum aggregate offering amount was $22,926,000, which includes shares of Common Stock having an aggregate sales price of $21,865,453 (23,631,319 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

On April 10, 2026, the Company filed Amendment No. 9 to the Prospectus Supplement (“Amendment No. 9”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale under General Instruction I.B.6. Following the filing of Amendment No. 9, the aggregate amount of shares that were available for sale was $1,282,000. The maximum aggregate offering amount was $24,208,000, which includes shares of Common Stock having an aggregate sales price of $22,925,309 (25,603,230 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

As of April 14, 2026, the aggregate market value of the Company’s outstanding shares of Common Stock held by non-affiliates, also known as the Company’s public float, was approximately $77,370,054, based on 39,676,951 shares of outstanding Common Stock held by non-affiliates as of April 14, 2026 and a price of $1.95 per share, the closing price of the Common Stock on March 3, 2026, which was within 60 days of April 14, 2026. Therefore, since the Company’s public float was above $75.0 million on April 14, 2026, the Company is no longer subject to the sales limitations of General Instruction I.B.6 of Form S-3.

 

On May 6, 2026, the Company filed Amendment No. 10 to the Prospectus Supplement (“Amendment No. 10”) further amending and supplementing the Prospectus Supplement, as amended, to further update the amount of shares eligible for sale and to indicate that the Company is no longer subject to the sales limitations of General Instruction I.B.6 of Form S-3. Following the filing of Amendment No. 10, the aggregate amount of shares that are available for sale is $65,000,000 (the “Placement Shares”). The maximum aggregate offering amount was $89,208,000, which includes the shares of Common Stock having an aggregate sales price of $24,207,305 (28,013,007 shares of Common Stock) that were previously sold pursuant to the Prospectus Supplement, as amended.

 

All other terms of the Offering and the ATM Agreement are described in the January 9th 8-K and the ATM Agreement, which is filed as Exhibit 10.1 to the January 9th 8-K.

 

The legal opinion of Ellenoff Grossman & Schole LLP, counsel to the Company, relating to the Placement Shares being offered is filed as Exhibit 5.1 to this Current Report on Form 8-K.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
5.1   Opinion of Ellenoff Grossman & Schole LLP
10.1*   At Market Issuance Sales Agreement, dated January 9, 2026, between the Trio Petroleum Corp and Ladenburg Thalmann Co. Inc.
23.1   Consent of Ellenoff Grossman & Schole LLP (included in Exhibit 5.1)
104   Cover Page Interactive Data File (embedded within the XBRL document)

 

* Incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the Commission on January 9, 2026

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 6, 2026  
   
Trio Petroleum Corp.  
     
By: /s/ Robin Ross  
Name: Robin Ross  
Title: Chief Executive Officer  

 

 

FAQ

What ATM program change did Trio Petroleum (TPET) report in this 8-K?

Trio Petroleum reported that Amendment No. 10 to its prospectus supplement increases the capacity of its at-the-market stock offering, allowing sales of up to $65,000,000 in common stock as Placement Shares under its existing S-3 registration statement and ATM agreement.

How large is Trio Petroleum’s total ATM offering after Amendment No. 10?

After Amendment No. 10, Trio Petroleum’s maximum aggregate offering amount under its ATM program is $89,208,000. This total includes both the newly available $65,000,000 of Placement Shares and common shares previously sold under the prospectus supplement and its amendments.

How much stock has Trio Petroleum already sold through the ATM?

Trio Petroleum states that common stock previously sold under the prospectus supplement, as amended, has an aggregate sales price of $24,207,305, representing 28,013,007 shares. These past sales are included in the updated maximum aggregate offering amount of $89,208,000 for the ATM program.

Why is Trio Petroleum no longer limited by General Instruction I.B.6 of Form S-3?

As of April 14, 2026, Trio Petroleum’s public float was about $77,370,054, based on 39,676,951 non-affiliate shares at $1.95 per share. Because this float exceeded $75.0 million, the company is no longer subject to the Form S-3 General Instruction I.B.6 sales limitations.

What registration statement and prospectus support Trio Petroleum’s ATM sales?

The ATM sales are made under Trio Petroleum’s Registration Statement on Form S-3, File No. 333-281813, which became effective on September 10, 2024. A base prospectus and a prospectus supplement, as amended by multiple amendments including No. 10, govern the offering of common stock through the ATM program.

Who is the sales agent for Trio Petroleum’s ATM offering?

Trio Petroleum’s at-the-market offering uses Ladenburg Thalmann & Co. Inc. as the sales agent. The relationship is governed by an At Market Issuance Sales Agreement dated January 9, 2026, which is referenced in the filing and incorporated by reference as Exhibit 10.1 to an earlier Form 8-K.

Filing Exhibits & Attachments

5 documents